BillionToOne, a molecular diagnostics company, announced the launch of a noninvasive test for pregnancies with high fetal chromosomal risks.The test, Unity Confirm, “selectively isolates intact ...
A breakthrough in prenatal care, Unity Confirm enables non-invasive confirmation for high-risk screening results through the capture of intact circulating fetal cells using BillionToOne's Fetal Cell ...